COMMUNIQUÉS West-GlobeNewswire

Constellation Pharmaceuticals to Present at Upcoming Investor Conferences

22/02/2019 - 19:24

CAMBRIDGE, Mass., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel [...]

Notice Convening the Annual General Meeting

22/02/2019 - 17:23

February 22, 2019 Announcement no. 3 NOTICE CONVENING THE ANNUAL GENERAL MEETING The Board of Directors hereby convenes the Annual General Meeting of BioPorto A / S (the “Company”): March 18, 2019, at 3.00 pm (CET), At [...]

Aura Health Provides Further Clarity Regarding Offering and Strategic Investor

22/02/2019 - 17:01

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. TORONTO, Feb. 22, 2019 ( [...]

DBV Technologies Announces Publication of Detailed Phase III Trial Results Evaluating Viaskin Peanut as a Novel Treatment for Peanut Allergy in The Journal of the American Medical Association

22/02/2019 - 17:00

Montrouge, France, February 22, 2019 DBV Technologies Announces Publication of Detailed Phase III Trial Results Evaluating Viaskin Peanut as a Novel Treatment for Peanut Allergy in The Journal of the American Medical [...]

DBV Technologies annonce la publication des résultats détaillés de l’essai clinique de phase III évaluant Viaskin Peanut comme un nouveau traitement de l’allergie à l’arachide dans le Journal of the American Medical Association

22/02/2019 - 17:00

Montrouge, France, le 22 février (17 : 00 CET) 2019 DBV Technologies annonce la publication des résultats détaillés de l’essai clinique de phase III évaluant Viaskin Peanut comme un nouveau traitement de l’allergie à l’ [...]

Innovate Biopharmaceuticals Announces a New Chief Executive Officer and Chief Medical Officer

22/02/2019 - 16:00

Management Plans to Hold a Conference Call on March 4, 2019 to Provide an Operational and Clinical Update RALEIGH, N.C., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals , Inc. (Nasdaq: INNT), a clinical [...]

Veritas Enrolls First Patient in Clinical Study to Assess Pain Control with Lead Product

22/02/2019 - 15:43

SAN JUAN, Puerto Rico, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Puerto Rico LLC, a wholly owned subsidiary of Veritas Pharma, Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas”), today announced the [...]

Coherus BioSciences Announces New Employment Inducement Grants

22/02/2019 - 15:30

REDWOOD CITY, Calif., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that effective February 21, 2019, the compensation committee of the company’s board of directors granted [...]

Merit Medical to Participate at Six Upcoming Conferences

22/02/2019 - 15:25

SOUTH JORDAN, Utah, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic [...]

Diversicare to Announce Fourth Quarter 2018 Financial Results on Thursday, February 28, 2019

22/02/2019 - 15:00

BRENTWOOD, Tenn., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ:DVCR) today announced that it is scheduled to report financial results for its fourth quarter ended December 31, 2018, on [...]

Trillium Announces Pricing of US$15 Million Public Offering of Common Share Units and Series II Non-Voting Convertible First Preferred Share Units

22/02/2019 - 15:00

TORONTO, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL) , a clinical stage immuno-oncology company developing innovative therapies for the treatment of [...]

New Research Further Demonstrates Clinical Utility and Improved Ease of Use with Daxor Corporation’s Blood Volume Analyzer (BVA-100®) in Critical Care

22/02/2019 - 14:37

NEW YORK, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today [...]

BioAg World Congress honors Pam Marrone with inaugural Lifetime Achievement Award

22/02/2019 - 14:31

DELHI, India, Feb. 22, 2019 (GLOBE NEWSWIRE) -- BioAgWorld Congress – Marrone Bio Innovations Inc. (NASDAQ:MBII), a leading global provider of bio-based pest management and plant health products, today announced that Dr [...]

ICC International Cannabis Corp. Competing in Explosive Worldwide Cannabis Market with Unique Global Strategy

22/02/2019 - 14:30

NEW YORK, NY, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Make no mistake about it the growth of the worldwide legal cannabis industry is exploding exponentially. One key driver behind this explosion is the many nations that have [...]

LeMaitre Vascular to Present at Upcoming Investor Conferences

22/02/2019 - 14:30

BURLINGTON, Mass., Feb. 22, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in two conferences in February. David Roberts, President, is scheduled to present [...]

Obalon Announces First Commercial Shipment of its Navigation Balloon Placement System with Touch Inflation Dispenser

22/02/2019 - 14:25

Obalon Navigation System™ with Touch™ Inflation Dispenser are intended to increase adoption of the Obalon Balloon by improving ease of administration and eliminating the need for x-ray imaging on placement SAN DIEGO, [...]

Interviews with CEO Denis Corin of Q BioMed and CEO George Nikopoulos of Mannin Research

22/02/2019 - 14:02

NEW YORK, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Q BioMed Inc. (OTCQB: QBIO ), a biotechnology acceleration company, announces multiple interviews with the company’s CEO, Denis Corin, and the Q BioMed team are now available [...]

Abeona Therapeutics Announces Participation in 8th Annual SVB Leerink Global Healthcare Conference

22/02/2019 - 14:01

NEW YORK and CLEVELAND, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company developing novel cell and gene therapies for serious diseases, today [...]

Dermira Initiates Proof-of-Concept Study to Evaluate QBREXZA™ (glycopyrronium) Cloth in Patients with Primary Palmar Hyperhidrosis

22/02/2019 - 14:00

- Study will assess the impact of QBREXZA treatment on sweat severity in patients with primary palmar hyperhidrosis - Results will inform potential development plans for QBREXZA in primary palmar hyperhidrosis - [...]